Literature DB >> 22943310

Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice.

Sa-Sa Gu1, Yan Zhang, Shu-Yan Wu, Teng-Yue Diao, Yoseph Asmelash Gebru, Hong-Wen Deng.   

Abstract

AIM: This study was performed to address the bone injury and the early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice.
METHODS: The male mice were subjected to unilateral ureteral obstruction (UUO, n = 10) or sham operation (n = 10). All mice were killed on day 7 after the surgical operation. Hematoxylin and eosin and tartate-resistant acid phosphatase staining were performed on paraffin-embedded bone sections. Expression of genes and proteins was analyzed by reverse transcription-polymerase chain reaction, and Western blotting and immunohistochemistry staining, respectively.
RESULTS: The serum calcium level was significantly reduced in UUO mice compared with that of Sham mice. The proximal tibia of UUO mice exhibited the increased expansion of chondrocytes zone, the reduction of osteoid content, and the increased separation and disconnection of woven bones. Reverse transcription-polymerase chain reaction results showed the downregulation of Cbfa1 and Col mRNA expression and the upregulation of Tgf-β, CtsK, CaII, Opg and Rankl mRNA expression in tibia of UUO mice compared to those of Sham mice. The ratio of Opg and Rankl was unchanged between Sham and the UUO group. Local protein expression of angiotensin II and its type 2 receptor was dramatically upregulated in tibia of UUO mice.
CONCLUSION: Together, it is concluded that the obstructive nephropathy has defective effects on bone, and the underlying mechanisms are the reduction of bone formation and the increase of bone resorption, which is mediated, at least partially through local angiotensin II signalling.
© 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943310     DOI: 10.1111/j.1440-1797.2012.01656.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  8 in total

1.  Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat.

Authors:  Yong Li; Guang-Si Shen; Chen Yu; Guang-Fei Li; Jun-Kang Shen; You-Jia Xu; Jian-Ping Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.

Authors:  Y Zhang; L Wang; Y Song; X Zhao; M S Wong; W Zhang
Journal:  Osteoporos Int       Date:  2015-10-06       Impact factor: 4.507

3.  Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.

Authors:  Teng-Yue Diao; Hai Pan; Sa-Sa Gu; Xi Chen; Fang-Yi Zhang; Man-Sau Wong; Yan Zhang
Journal:  J Bone Miner Metab       Date:  2013-08-10       Impact factor: 2.626

4.  Trabecular bone deterioration at the greater trochanter of mice with unilateral obstructive nephropathy.

Authors:  Sa-Sa Gu; Yan Zhang; Xi Chen; Teng-Yue Diao; Yoseph Gebru; Man-Sau Wong
Journal:  Asian J Androl       Date:  2013-05-06       Impact factor: 3.285

5.  Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Dina Sabry; Mahmoud M Khattab; Salim S Al-Rejaie
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

Review 6.  Potential of RAS inhibition to improve metabolic bone disorders.

Authors:  Yoseph Gebru; Teng-Yue Diao; Hai Pan; Emmanuel Mukwaya; Yan Zhang
Journal:  Biomed Res Int       Date:  2013-07-22       Impact factor: 3.411

7.  Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice.

Authors:  Xiang-Fan Chen; Xiao-Li Li; Jin-Xin Liu; Jing Xu; Yan-Yan Zhao; Min Yang; Yan Zhang
Journal:  Pharmacol Rep       Date:  2018-02-07       Impact factor: 3.024

8.  Type I Angiotensin II Receptor Blockade Reduces Uremia-Induced Deterioration of Bone Material Properties.

Authors:  Takuya Wakamatsu; Yoshiko Iwasaki; Suguru Yamamoto; Koji Matsuo; Shin Goto; Ichiei Narita; Junichiro J Kazama; Kennichi Tanaka; Akemi Ito; Ryosuke Ozasa; Takayoshi Nakano; Chisato Miyakoshi; Yoshihiro Onishi; Shingo Fukuma; Shunichi Fukuhara; Hideyuki Yamato; Masafumi Fukagawa; Tadao Akizawa
Journal:  J Bone Miner Res       Date:  2020-10-02       Impact factor: 6.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.